Jong Taek Kim
No Rating Available
(Learn About Our Rating System)

Jong Taek Kim, MD, MS

Languages spoken: English

  • Specialties

    • Pathology, Anatomical

    Board Certification

    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Clinical Informatics)
    American Board of Pathology (Sub: Molecular Genetic Pathology)
    National Board of Medical Examiners

  • Board Certification and Academic Information

    Academic Departments Pathology -Assistant Professor (Clinical)
    Board Certification
    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Clinical Informatics)
    American Board of Pathology (Sub: Molecular Genetic Pathology)
    National Board of Medical Examiners

    Education history

    Fellowship Molecular Genetics Pathology - Cedars-Sinai Medical Center Fellow
    Graduate Training Biomedical Informatics - University of Florida College of Medicine M.S.
    Residency Anatomic and Clinical Pathology - University of Florida College of Medicine Co-Chief Resident
    Residency Anatomic and Clinical Pathology - University of Florida College of Medicine Resident
    Residency Orthopaedic Surgery - Medical University of South Carolina Resident
    Doctoral Training Medicine - University of South Alabama College of Medicine M.D.
    Undergraduate Major: Biology; Minor: Chemistry - University of Mississippi B.S.

    Selected Publications

    Journal Article

    1. Beech C, Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim J, Coleman JF, Deftereos G, Gulbahce EH, Sirohi D (2025). Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization. Appl Immunohistochem Mol Morphol, 33(2), 91-102. (Read full publication)
    2. Wilcock D, Sirohi D, Coleman JF, Adelhardt P, Kim JT, Albertson D, Affolter K, Beech C, Jedrzkiewicz J, Ruano AL, Cleary AS, Mahlow J, Balatico M, Gulbahce HE (2025). HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as positive after targeted recounts following equivocal (2+) immunohistochemistry. Am J Clin Pathol, 163(6), 837-846. (Read full publication)
    3. Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Burlingame J, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim JT, Coleman JF, Deftereos G, Gulbahce EH, Sirohi D (2023). Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer. Arch Pathol Lab Med. (Read full publication)
    4. Wilcock DM, McMurtry V, Coleman JF, Kim JT, Khalili P, Deftereos G, Albertson D, Gulbahce EH, Liu T, Sirohi D (2022). Histopathological Correlation of Chromosome 12 Polysomy by Fluorescence in Situ Hybridization in Adipocytic Neoplasms. Int J Surg Pathol, 30(7), 10668969221085289. (Read full publication)
    5. Wong M, Kim JT, Cox B, Larson BK, Kim S, Waters KM, Vail E, Guindi M (2021). Evaluation of Tumor Mutational Burden in Small Early Hepatocellular Carcinoma and Progressed Hepatocellular Carcinoma. Is There a Difference? . Hepat Oncol, 8(4), HEP39. (Read full publication)
    6. Kim JT, Harris NS (2019). Utilization Review of Paraneoplastic Neurological Syndrome Antibody Screening Panels: Experience at a Tertiary Academic Health Center. J Appl Lab Med, 4(1), 19-29. (Read full publication)
    7. Shon W, Kim J, Sukov W, Reith J (2015). Malignant TFE3-rearranged perivascular epithelioid cell neoplasm (PEComa) presenting as a subcutaneous mass. Br J Dermatol, 174(3), 617-20. (Read full publication)
    8. Kim JT, Rudolf LM, Glaser JA (2013). Outcome of percutaneous sacroiliac joint fixation with porous plasma-coated triangular titanium implants: an independent review. Open Orthop J, 7, 51-6. (Read full publication)
    9. Grishko V, Xu M, Ho R, Mates A, Watson S, Kim JT, Wilson GL, Pearsall AW 4th (2009). Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes. J Biol Chem, 284(14), 9132-9. (Read full publication)

    Case Report

    1. Taek Kim J, Zhang W, Lopategui J, Vail E, Balmanoukian A (2022). Patient With Stage IV NSCLC and CNS Metastasis With EGFR Exon 18-25 Kinase Domain Duplication With Response to Osimertinib as a First-Line Therapy. JCO Precis Oncol, 5, 88-92. (Read full publication)
    2. Gower A, Kim J, Spector K, Menashe D, Vail E, Natale R (2020). Three Primary Tumors Including EGFR-mutated Non-Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni Syndrome. Clin Lung Cancer, 22(1), e116-e121. (Read full publication)

    Letter

    1. Kim JT, Winter WE, Luo HY, Chui DHK, Harris NS (2018). Interference of Hemoglobin A1c Due to Hemoglobin Franklin Park. [Letter to the editor]. J Appl Lab Med, 3(5), 911-913. (Read full publication)
    2. Kim JT, Newsom KJ, Shon W (2017). Detection of somatic mutations in secondary tumors associated with nevus sebaceus by targeted next generation sequencing. Comment on Kitamura et al. [Letter to the editor]. Int J Dermatol, 57(1), 120-122. (Read full publication)

    Other

    1. Zhang W, Govindavari JP, Davis BD, Chen SS, Kim JT, Song J, Lopategui J, Plummer JT, Vail E (2020). Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic. JAMA Netw Open (3(10), pp. e2024191). United States. (Read full publication)
    2. Vail E, Song J, Xu J, Frye JS, Kim JT, Pao A, Schreck R, Aguiluz AS, Zhang W, Alkan S, Mita A, Mita M, Figlin RA, Engman DM, Lopategui JR (2020). Comparison of Large, Medium, and Small Solid Tumor Gene Panels for Detection of Clinically Actionable Mutations in Cancer. Target Oncol (15(4), pp. 523-530). France. (Read full publication)